Indolent Lymphoma
Showing 1 - 11 of 11
CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)
Recruiting
- CLL
- +9 more
- TG-1801
- Ublituximab
-
Fayetteville, Arkansas
- +4 more
Jan 20, 2023
Indolent Lymphoma, Low-dose Radiotherapy Trial in Beijing (Low-dose radiotherapy)
Recruiting
- Indolent Lymphoma
- Low-dose Radiotherapy
- Low-dose radiotherapy
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Sep 13, 2022
Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Trial in Australia, United States (NKX019)
Recruiting
- Lymphoma, Non-Hodgkin
- +9 more
- NKX019
-
Denver, Colorado
- +6 more
Jan 19, 2022
Indolent Lymphoma Trial in Tel Aviv (vegan diet and lifestyle changes)
Recruiting
- Indolent Lymphoma
- vegan diet and lifestyle changes
-
Tel Aviv, IsraelTel-Aviv Sourasky Medical Center
Jul 5, 2021
Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma Trial in Tucson (rituximab, bortezomib, cladribine)
Completed
- Lymphoma
- +3 more
- rituximab
- +2 more
-
Tucson, ArizonaThe University of Arizona Cancer Center
Dec 16, 2019
Indolent Lymphoma Trial (Ledipasvir and sofosbuvir)
Unknown status
- Indolent Lymphoma
- Ledipasvir and sofosbuvir
- (no location specified)
Aug 23, 2017
Indolent Lymphoma Trial in Ludwigshafen (Therapy with Rituximab, Gemcitabine and Oxaliplatin)
Terminated
- Indolent Lymphoma
- Therapy with Rituximab, Gemcitabine and Oxaliplatin
-
Ludwigshafen, GermanyKlinikum Ludwigshafen
Aug 17, 2015
11C-Acetate PET/CT Non-FDG-Avid Tumors
Unknown status
- Soft Tissue Sarcomas
- +9 more
-
Tel Aviv, IsraelDepartment of Nuclear Medicine, Tel Aviv Sourasky Medical Center
May 30, 2008